-
Cy5-UTP RNA Labeling for Imaging Workflows
2026-09-22
Cy5-UTP enables direct far-red detection of T7-transcribed RNA for FISH, multicolor localization, and dual-color expression arrays. This workflow also shows how labeled RNA readouts can complement studies of intracellular trafficking without confusing particle uptake with functional RNA delivery.
-
PTC124 (Ataluren): Assay Strategy in Lowe Syndrome
2026-09-22
PTC124 (Ataluren) is best evaluated in Lowe syndrome through a genotype-first workflow that distinguishes premature-stop readthrough from true OCRL restoration. This article translates recent patient-derived trabecular meshwork findings into practical assay decisions without confusing pharmacologic rescue with gene therapy.
-
PORCN Inhibition for Sclerosteosis: Study Insights
2026-09-21
A 2025 Bone Research study tested the PORCN inhibitor LGK974 as a pharmacological strategy for SOST-deficient high-bone-mass disease. Combined osteoblast, osteoclast, mouse, mechanical-loading, microcomputed tomography, and molecular analyses indicate reduced pathological bone formation, while sex-dependent Axin2 responses highlight important translational questions.
-
Ceramides Drive RGNNV Replication via Autophagy
2026-09-21
A recent Journal of Virology study uses global lipidomics and targeted perturbation experiments to show that ceramide accumulation supports red-spotted grouper nervous necrosis virus replication. The work connects viral capsid protein activity, three ceramide-generating routes, and autophagy, providing a mechanistic framework for studying lipid-dependent pathogenesis in aquaculture viruses.
-
Caspase-3 Colorimetric Assay Kit Guide
2026-09-20
The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a plate-based readout of DEVD-dependent caspase-3 activity through release of p-nitroaniline from DEVD-pNA. It is suited to controlled apoptosis and biochemical caspase activity measurement, but it should not be treated as a standalone proof of caspase-3 identity, pathway order, or tissue-specific biological effect.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-09-19
The reference study shows that murine norovirus repurposes the membrane-rupture factor NINJ1 to release the viral protein NS1 through an unconventional secretion pathway. Its combination of CRISPR screening, caspase-3 perturbation, localization studies, mutagenesis, and mouse infection experiments provides a mechanistic framework for understanding how viral proteins can be selectively exported during host-cell death.
-
740 Y-P and PI3K: A Mechanistic Assay Guide
2026-09-18
Explore how 740 Y-P, a cell-permeable PI 3-kinase activator, can help dissect PI3K/AKT signaling, autophagy, and stress-response assays. This guide translates recent BMSC findings into practical, hypothesis-driven experimental decisions without treating one pathway readout as proof of mechanism.
-
Decitabine Workflows for Cancer Epigenetics
2026-09-18
Build reproducible Decitabine assays for DNA hypomethylation, tumor suppressor gene reactivation, and dose-dependent cancer-cell responses. A practical workflow also shows how the compound can support exploratory immune-epigenetic studies inspired by psoriasis autoantigen research.
-
AMPK Rewrites Autophagy Under Energy Stress
2026-09-17
Park, Lee, and Kim challenge the prevailing view that AMPK universally activates autophagy during glucose deprivation. Their data indicate that AMPK suppresses ULK1–Atg14–Vps34 signaling during severe energy stress while preserving the autophagy machinery for recovery, a distinction that changes how nutrient-starvation experiments should be interpreted.
-
Programmed Cell Death in Heart Disease: Mechanisms
2026-09-17
The reference review reframes cardiac injury by showing that apoptosis and necrosis are distinct but interconnected, regulated processes rather than simple alternatives of active and passive death. Its pathway-based synthesis helps researchers design experiments that distinguish death morphology, energetic failure, receptor signaling, and organelle injury while evaluating how cell-death modulation may translate to pulmonary fibrosis research.
-
BML-277: Chk2 Inhibitor for DNA Damage
2026-09-16
BML-277 is a potent, selective Chk2 inhibitor for connecting biochemical checkpoint control with T-cell radioprotection and nuclear genome-stability assays. This workflow-focused guide shows how to use concentration-appropriate dosing, pathway controls, and orthogonal readouts to study DNA damage response signaling without overinterpreting a single inhibitor phenotype.
-
SARS-CoV-2 RNAi Screen Maps Vesicle-Mediated Release
2026-09-16
Kerr et al. used an arrayed, druggable-genome RNA interference screen with two production timepoints to identify host factors acting across the SARS-CoV-2 replication and reinfection cycle. The study highlights Rab11a-associated vesicular transport as a conserved determinant of viral release and shows that pharmacological CDK9 inhibition can block this late-stage process.
-
4-Methoxychalcone-1: Evidence and Limits
2026-09-15
4-Methoxychalcone-1, SKU C8661, is cataloged as a research product, but the supplied evidence does not establish its activity in retinal neovascularization. The cited study evaluates scutellarin, a different molecule, in hypoxic rat retinal endothelial cells and therefore supports assay rationale rather than a direct product claim.
-
Fosinopril Sodium for Hypertension Research
2026-09-15
Fosinopril sodium combines potent ACE inhibition with a prodrug workflow that can connect enzyme assays, vascular studies, and cardiovascular disease models. This guide shows how to build reproducible experiments, manage hydrolysis and solubility variables, and use catalpol-focused cardiovascular evidence to select complementary readouts.
-
5-EdU Workflows for S-Phase DNA Detection
2026-09-14
Learn how 5-Ethynyl-2'-deoxyuridine (5-EdU) converts short DNA-synthesis pulses into quantitative fluorescence readouts for imaging and flow cytometry. The workflow emphasizes cardiomyocyte endoreplication, tumor growth research, tissue regeneration studies, and practical troubleshooting beyond conventional BrdU assays.